145 related articles for article (PubMed ID: 34780937)
1. Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.
Wu Y; Li Y; Wang M; Li W; Qiu X
Ann Vasc Surg; 2022 Mar; 80():325-332. PubMed ID: 34780937
[TBL] [Abstract][Full Text] [Related]
2. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
4. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
5. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
[TBL] [Abstract][Full Text] [Related]
6. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract][Full Text] [Related]
7. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
10. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
11. Endovascular Stenting in Superior Vena Cava Syndrome: A Systematic Review and Meta-analysis.
Aung EY; Khan M; Williams N; Raja U; Hamady M
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1236-1254. PubMed ID: 35821122
[TBL] [Abstract][Full Text] [Related]
12. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer.
Urruticoechea A; Mesía R; Domínguez J; Falo C; Escalante E; Montes A; Sancho C; Cardenal F; Majem M; Germà JR
Lung Cancer; 2004 Feb; 43(2):209-14. PubMed ID: 14739042
[TBL] [Abstract][Full Text] [Related]
14. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
15. Stent placement in superior vena cava syndrome.
Courtheoux P; Alkofer B; Al Refaï M; Gervais R; Le Rochais JP; Icard P
Ann Thorac Surg; 2003 Jan; 75(1):158-61. PubMed ID: 12537210
[TBL] [Abstract][Full Text] [Related]
16. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
[TBL] [Abstract][Full Text] [Related]
17. Malignant obstruction of superior vena cava: Endovascular stenting using Y-configuration stent in stent technique.
Noor Khairiah AK; Mohamad Nazrulhisham MN; Hazman MN
Med J Malaysia; 2018 Dec; 73(6):407-409. PubMed ID: 30647215
[TBL] [Abstract][Full Text] [Related]
18. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
[TBL] [Abstract][Full Text] [Related]
19. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
